Why Advanced Biomed Inc.’s (ADVB) Stock Is Down 7.93%
As of Tuesday, April 08, Advanced Biomed Inc.’s ADVB share price has dipped by 7.93%, which has investors questioning if this is right time to buy.Jenna Brashear
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Jenna Brashear
Cynthia McLaughlin
Jenna Brashear
| Share Statistics | ADVB | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2.7 | $363.7 | 3% |
|
| Shares Out (Mil) | 1.7 | 41.1 | 7% |
|
| Institutional Ownership | 13.8% | 82.7% | 7% |
|
| Float (Mil) | 1.0 | 36.7 | 3% |
|
| Beta | na | 0.89 | na |
|
| Avg Daily Volume (000s) | 126 | 326 | 38% |
|
| Price Change (52-week) |
(79.3%) | 54.6% | 10% |
|
| Growth | ADVB | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | 41.7% | (5.8%) | 91% |
|
| EPS (5yr) | 29.6% | 10.6% | 81 |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (15.6%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | ADVB | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $0 | $123 | 0% |
|
| Net Income (TTM) (Mil) | $6 | ($9) | 42% |
|
| EPS (TTM) | $4.354 | ($0.300) | 84% |
|
| Operating Cash Flow (TTM) (Mil) | ($2) | ($1) | 30% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $21 | 0% |
|
| Enterprise Value (Q1) (Mil) | $5 | $381 | 7% |
|
| Valuation | ADVB | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.25 | 2.41 | 6% |
|
| P/E | na | 25.5 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.3 | na |
|
| Ratios | ADVB | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 100.0% | 59.5% | 96% |
|
| Net Margin | na | (5.0%) | na |
|
| ROA | 63.5% | (10.4%) | 99% |
|
| ROE | 85.0% | (8.4%) | 96% |
|
| Liabilities to Assets | 12.5% | 45.8% | 8% |
|
| F-Score | 5 | 4 | 50% |
|
Advanced Biomed Inc. did not pass any screens on 11/20/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors